NFKB1 and arthritic joint disease: NF-κB blockade with NF-κB decoy ODN has also been shown to inhibit the development of arthritis and joint destruction in various animal models of arthritis [44,129,130], and to inhibit NF-κB activity ex vivo in human synovial cells derived from patients with RA [131].